Appeals Court to Hear Gene-Patenting Case in July
By Maggie Fox,
National Journal
| 04. 30. 2012
A federal appeals court will hear arguments about whether companies can patent genes on July 20. The American Civil Liberties Union has challenged Myriad Genetics’ patents on the BRCA 1 and BRCA2 genes, which affect the risk of breast and ovarian cancer. The Supreme Court sent the case back to the Court of Appeals for the Federal Circuit last month.
The ACLU pointed out that studies have shown a new class of cancer drugs called PARP inhibitors can help cancer patients with specific BRCA mutations.”However, the FDA (Food and Drug Administration) will not approve the drugs unless all accompanying diagnostic tests are also FDA-approved. Myriad’s tests – like most genetic tests – have not been approved by the FDA,” the ACLU said in a statement.
“You’d think that Myriad would submit to FDA approval so that these drugs can make their way to the people that need them, but they have not. As a consequence,Myriad’s patents are preventing women from learning if they have the genes and preventing them from getting the treatment they need if they do.”
Any court...
Related Articles
A Review of Exposed by Becky McClain
“Do not get lost in a sea of despair. Be hopeful, be optimistic. Our struggle is not the struggle of a day, a week, a month, or a year, it is the struggle of a lifetime. Never, ever be afraid to make some noise and get in good trouble, necessary trouble.”
— John Lewis
Becky McClain became famous when she successfully sued Pfizer, one of the very largest pharmaceutical and biotech companies. She...
By Katherine Long, Ben Foldy, and Lingling Wei, The Wall Street Journal | 12.13.2025
Inside a closed Los Angeles courtroom, something wasn’t right.
Clerks working for family court Judge Amy Pellman were reviewing routine surrogacy petitions when they spotted an unusual pattern: the same name, again and again.
A Chinese billionaire was seeking parental...
By Sarah Kliff, The New York Times | 12.10.2025
Micah Nerio had known since his early 30s that he wanted to be a father, even if he did not have a partner. He spent a decade saving up to pursue surrogacy, an expensive process where he would create embryos...
By Carter Sherman, The Guardian | 12.08.2025
A huge defense policy bill, revealed by US lawmakers on Sunday, does not include a provision that would have provided broad healthcare coverage for in vitro fertilization (IVF) for active-duty members of the military, despite Donald Trump’s pledge...
